Shilpa Medicare Ltd Analyst Rating
based on 2 analysts
100.00%
Buy
0.00%
Hold
0.00%
Sell
Based on 2 analysts offering long term price targets for Shilpa Medicare Ltd. An average target of ₹1208
Source: S&P Global Market Intelligence
Shilpa Medicare Ltd Share analysis
Shilpa Medicare Ltd price forecast by 2 analysts
Upside of45.82%
High
₹1525
Target
₹1208.00
Low
₹891
Shilpa Medicare Ltd target price ₹1208, a slight upside of 45.82% compared to current price of ₹813.15. According to 2 analysts rating.
Excluding Excise Duty and Other Income, represents Net Revenue
Shilpa Medicare Ltd revenue growth forecast
Expected growth rate Q1, FY2026:49.22%
Forecast
Actual
Including amortisation and stock based compensations
Shilpa Medicare Ltd EPS growth forecast
EPS estimate Q1, FY2026:205.44%
Forecast
Actual
Source: S&P Global Market Intelligence
Shilpa Medicare Ltd Performance
Day's Low
Day's High
₹799.85Day's Price Range₹844.352 Week's Low
52 Week's High
₹313.1552-Week Price Range₹959.5
| Returns % | |
| 1 Month Return | -11.5 % |
| 3 Month Return | -3.33 % |
| 1 Year Return | + 127.36 % |
| Market Stats | |
| Previous Close | ₹828.40 |
| Open | ₹832.00 |
| Volume | 3.05L |
| Upper Circuit | - |
| Lower Circuit | - |
| Market Cap | ₹8,120.56Cr |
Shilpa Medicare Ltd Key Statistics
| P/E Ratio | 124.76 |
| PEG Ratio | 15.59 |
| Market Cap | ₹8,120.56 Cr |
| P/B Ratio | 1.87 |
| EPS | 3.68 |
| Dividend Yield | 0 |
| Sector | Pharmaceuticals |
| ROE | 1.59 |
Shilpa Medicare Ltd Peer Comparison
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
|---|---|---|---|---|---|---|
| BUY | ₹8,120.56 Cr | 37.6% | 0.53 | ₹31 Cr | ₹1,151 Cr | |
| BUY | ₹31,730.25 Cr | 124.37% | 0.52 | ₹300 Cr | ₹1,051 Cr | |
| BUY | ₹17,358.12 Cr | 27.29% | 0.57 | ₹72 Cr | ₹6,702 Cr | |
| NA | ₹7,074.57 Cr | 6.9% | 0.79 | -₹388 Cr | ₹75 Cr | |
| BUY | ₹16,238.11 Cr | 49.95% | 0.68 | ₹218 Cr | ₹1,296 Cr |
Shilpa Medicare Ltd Mutual Fund Holdings
About Shilpa Medicare Ltd
Share Price: ₹813.15 per share as on 20 Dec, 2024 04:01 PM
Market Capitalisation: ₹8,120.56Cr as of today
Revenue: ₹343.80Cr as on September 2024 (Q3 24)
Net Profit: ₹17.94Cr as on September 2024 (Q3 24)
Listing date: 03 Dec, 2009
Chairperson Name: Omprakash Inani
| Organisation | Shilpa Medicare Ltd |
| Headquarters | |
| Industry | Pharmaceuticals |
| E-voting on shares | Click here to vote |
Key events for Shilpa Medicare Ltd
Shilpa Medicare Secures GMP Certification in Hyderabad - 20 Dec, 2024
Shilpa Medicare announced the receipt of Good Manufacturing Practice (GMP) certification for its Unit VII in Hyderabad following a successful inspection by the EMA. This certification underscores the company's commitment to quality standards in its operations.Shilpa Medicare's JV Secures FDA Approval for IMKELDI - 27 Nov, 2024
Shilpa Medicare's joint venture with Zydus and Shorla Oncology has received US FDA approval for IMKELDI, an oral liquid formulation of imatinib for cancer treatment. The company reported strong financial results, with a 28% sequential net profit increase and 1014% year-on-year growth.Shilpa Medicare Approved for Phase III Trials - 26 Nov, 2024
Shilpa Medicare has received approval from the Subject Expert Committee to conduct Phase III clinical trials for its Recombinant Human Albumin (rHA) 20%. This positions Shilpa as the first Indian company to advance in this area, addressing global supply challenges for human serum albumin.
Insights on Shilpa Medicare Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTRevenue Rich
Revenue is up for the last 4 quarters, 288.7 Cr → 348.79 Cr (in ₹), with an average increase of 6.0% per quarter
- POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 2 quarters, 14.06 Cr → 17.94 Cr (in ₹), with an average increase of 21.6% per quarter
- POSITIVE IMPACT
Best in 1 Year
In the last 1 year, SHILPAMED has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
- POSITIVE IMPACT
FII Holding Up
Foreign Institutions have increased holdings from 9.08% to 9.58% in Sep 2024 quarter
- POSITIVE IMPACT
MF Holding Up
Mutual Funds have increased holdings from 5.03% to 5.09% in Sep 2024 quarter
NO EFFECTAgainst Peers
In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 135.8% return, outperforming this stock by 78.8%
NEGATIVE IMPACTPromoter Holding Down
Promoters have decreased holdings from 44.39% to 44.33% in Sep 2024 quarter
- NEGATIVE IMPACT
Retail Holding Down
Retail Investor have decreased holdings from 38.92% to 37.90% in Sep 2024 quarter
- NEGATIVE IMPACT
Price Dip
In the last 1 month, SHILPAMED stock has moved down by -5.7%
Shilpa Medicare Ltd Financials
Index Inclusions
Shilpa Medicare Ltd Shareholding Pattern
| Investors | Holdings % | FY Quarter | 3M change |
|---|---|---|---|
| Promoter Holdings | 44.33% | ||
| Foreign Institutions | 9.58% | 5.53 | |
| Mutual Funds | 5.09% | 1.24 | |
| Retail Investors | 37.9% | ||
| Others | 3.1% | 19.89 |
Shilpa Medicare Ltd Key Indicators
Shilpa Medicare Ltd Valuation
Shilpa Medicare Ltd in the last 5 years
Lowest (-6579.29x)
March 28, 2024
Industry (56.23x)
December 19, 2024
Today (124.76x)
December 19, 2024
Highest (503.73x)
February 21, 2023
Shilpa Medicare Ltd Earnings and Dividends
Shilpa Medicare Ltd Earnings Results
Shilpa Medicare Ltd’s net profit jumped 1014.29% since last year same period to ₹17.94Cr in the Q2 2024-2025. On a quarterly growth basis, Shilpa Medicare Ltd has generated 27.6% jump in its net profits since last 3-months.
Read More about Earnings ResultsShilpa Medicare Ltd Dividends May,2022
In the quarter ending March 2022, Shilpa Medicare Ltd has declared dividend of ₹1.10 - translating a dividend yield of 0.27%.
Read More about Dividends
Shilpa Medicare Ltd Technicals Summary
Bearish
Neutral
Bullish
Shilpa Medicare Ltd is currently in a Bearish trading position according to technical analysis indicators.
FAQs on Shilpa Medicare Ltd
- Get a PAN card.
- Open a Demat account.
- Open a Trading account.
- Link your Demat account to your Trading account.
- Fund your Trading account.
- Place an order to buy Shilpa Medicare Ltd shares.
Shilpa Medicare Ltd (SHILPAMED) share price today is ₹813.15
Shilpa Medicare Ltd is listed on NSE
Shilpa Medicare Ltd is listed on BSE
- Today’s highest price of Shilpa Medicare Ltd is ₹844.3.
- Today’s lowest price of Shilpa Medicare Ltd is ₹799.85.
PE Ratio of Shilpa Medicare Ltd is 124.76
PE ratio = Shilpa Medicare Ltd Market price per share / Shilpa Medicare Ltd Earnings per share
Today’s traded volume of Shilpa Medicare Ltd(SHILPAMED) is 3.05L.
Today’s market capitalisation of Shilpa Medicare Ltd(SHILPAMED) is ₹8120.56Cr.
| Shilpa Medicare Ltd(SHILPAMED | Price |
|---|---|
52 Week High | ₹959.5 |
52 Week Low | ₹313.15 |
Shilpa Medicare Ltd(SHILPAMED) share price is ₹813.15. It is down -15.25% from its 52 Week High price of ₹959.5
Shilpa Medicare Ltd(SHILPAMED) share price is ₹813.15. It is up 159.67% from its 52 Week Low price of ₹313.15
| Shilpa Medicare Ltd(SHILPAMED | Returns |
|---|---|
1 Day Returns | -15.25% |
1 Month Returns | -11.5% |
3 Month Returns | -3.33% |
1 Year Returns | 127.36% |